Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 42
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Jasmonate signaling involves the abscisic acid receptor PYL4 to regulate metabolic reprogramming in Arabidopsis and tobacco

  • Lackman, Petri
  • González Guzmán, Miguel
  • Tilleman, Sofie
  • Carqueijeiro, Ines
  • Perez Cuellar, Amparo
  • Moses, Tessa
  • Seo, Mitsunori
  • Kanno, Yuri
  • Hakkinen, Suvi T
  • Van Montagu, Marc C. E
  • Thevelein, Johan
  • Maaheimo, Hannu
  • Oksman-Caldentey, Kirsi-Marja
  • Rischer, Heiko
  • Goossens, Alain
  • Rodríguez Egea, Pedro Luís|||0000-0002-5886-9425
[EN] The phytohormones jasmonates (JAs) constitute an important class of elicitors for many plant secondary metabolic pathways. However, JAs do not act independently but operate in complex networks with crosstalk to several other phytohormonal signaling pathways. Here, crosstalk was detected between the JA and abscisic acid (ABA) signaling pathways in the regulation of tobacco (Nicotiana tabacum) alkaloid biosynthesis. A tobacco gene from the PYR/PYL/RCAR family, NtPYL4, the expression of which is regulated by JAs, was found to encode a functional ABA receptor. NtPYL4 inhibited the type-2C protein phosphatases known to be key negative regulators of ABA signaling in an ABA-dependent manner. Overexpression of NtPYL4 in tobacco hairy roots caused a reprogramming of the cellular metabolism that resulted in a decreased alkaloid accumulation and conferred ABA sensitivity to the production of alkaloids. In contrast, the alkaloid biosynthetic pathway was not responsive to ABA in control tobacco roots. Functional analysis of the Arabidopsis (Arabidopsis thaliana) homologs of NtPYL4, PYL4 and PYL5, indicated that also in Arabidopsis altered PYL expression affected the JA response, both in terms of biomass and anthocyanin production. These findings define a connection between a component of the core ABA signaling pathway and the JA responses and contribute to the understanding of the role of JAs in balancing tradeoffs between growth and defense., We thank Freya Lammertyn, Robin Vanden Bossche, Lander Ingelbrecht, Astrid Nagels Durand, Laurens Pauwels, Jacob Pollier, Siv Matomaa, Jaana Rikkinen, and Yuji Kamiya for excellent technical assistance and advice; Wilson Ardiles-Diaz for sequencing the cDNA–amplified fragment length polymorphism tags; and Martine De Cock for help in preparing the manuscript. This work was supported by the European FP7 project SMARTCELL (222716) and the Spanish Ministry for Science and Innovation (Grant BIO2008-00221 to P.L.R.). S.T., T.M., and P.L. are indebted to the Agency for Innovation by Science and Technology, the VIB International Ph.D. Fellowship Program for predoctoral fellowships and the Glycoscience Graduate School, respectively. M.G.-G is supported by a “Juan de la Cierva” contract from the Spanish Ministry for Science and Innovation.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Engineering complex metabolic pathways in plants

  • Farré Martinez, Gemma
  • Capell Capell, Teresa
  • Zhu, Changfu
  • Christou, Paul
  • Blancquaert, Dieter
  • Van Der Straeten, Dominique
Metabolic engineering can be used to modulate endogenous metabolic pathways in plants or introduce new metabolic capabilities in order to increase the production of a desirable compound or reduce the accumulation of an undesirable one. In practice, there are several major challenges that need to be overcome, such as gaining enough knowledge about the endogenous pathways to understand the best intervention points, identifying and sourcing the most suitable metabolic genes, expressing those genes in such a way as to produce a functional enzyme in a heterologous background, and, finally, achieving the accumulation of target compounds without harming the host plant. This article discusses the strategies that have been developed to engineer complex metabolic pathways in plants, focusing on recent technological developments that allow the most significant bottlenecks to be overcome., Research at the Universitat de Lleida is supported by MICINN, Spain (BIO2011-23324, BIO02011-22525, BIO2012-35359, and PIM2010PKB-00746); European Union Framework 7 Program–SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE (to P.C.); RecerCaixa; COST Action FA0804 (Molecular Farming: Plants as a Production Platform for High Value Proteins); and Centre CONSOLIDER on Agrigenomics, funded by MICINN, Spain. Research at Ghent University is supported by Bijzonder Onderzoeksfonds (BOF2004/GOA/012 and BOF2009/GOA/004 to D.V.D.S.) and the Research Foundation Flanders (3G012609 to D.V.D.S.). D.B. is indebted to the Research Foundation Flanders for a PhD fellowship.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Metabolic engineering of plant secondary products: which way forward?

  • Miralpeix i Anglada, Bruna
  • Rischer, Heiko
  • Häkkinen, Suvi T.
  • Ritala, Anneli
  • Seppänen-Laakso, Tuulikki
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
  • Christou, Paul
Secondary products are small molecular weight compounds produced by secondary metabolic pathways in plants. They are re- garded as non-essential for normal growth and development but often confer benefits such as defense against pathogens, pests an d herbi- vores or the attraction of pollinators. Many secondary products affect the survival and/or behavior of microbes, insects and ma mmals and they often have useful pharmacological effects in humans. Most secondary products can only be obtained as extracts from medicin al plants, many of which grow slowly and are difficult to cultivate. Chemical synthesis, although possible in principle, is often impractical or uneconomical due to the complexity of their molecular structures. The large scale production of secondary products by metabo lic en- gineering has therefore been investigated in a number of heterologous systems including microbes, plant cell/organ cultures, an d intact plants. In this critical review of production platforms for plant secondary products, we discuss the advantages and constraints of different approaches and the impact of post-genomics technologies on gene discovery and metabolite analysis. We highlight bottlenecks that re- main to be overcome before the routine exploitation of secondary products can be achieved for the benefit of mankind., Research is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); Euro- pean Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Ac- tion FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA1006: Plant metabolic engineering for high value products; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

The application of GMOs in agriculture and in food production for a better nutrition: two different scientific points of view

  • Christou, Paul
  • Buiatti, M.
  • Pastore, G.
This commentary is a face-to-face debate between two almost opposite positions regarding the application of genetic engineering in agriculture and food production. Seven questions on the potential benefits of the application of genetic engineering in agriculture and on the potentially adverse impacts on the environment and human health were posed to two scientists: one who is sceptical about the use of GMOs in Agriculture, and one who views GMOs as an important tool for quantitatively and qualitatively improving food production., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Can the world afford to ignore biotechnology solutions that address food insecurity?

  • Berman Quintana, Judit
  • Zhu, Changfu
  • Pérez Massot, Eduard
  • Arjó Pont, Gemma
  • Zorrilla López, Uxue
  • Masip Vilà, Gemma
  • Banakar, Raviraj
  • Sanahuja Solsona, Georgina
  • Farré Martinez, Gemma
  • Miralpeix i Anglada, Bruna
  • Bai, Chao
  • Vamvaka, Evangelia
  • Sabalza Gallués, Maite
  • Twyman, Richard M.
  • Bassie Rene, Ludovic
  • Capell Capell, Teresa
  • Christou, Paul
Genetically engineered (GE) crops can be used as part of a combined strategy to address food insecurity, which is defined as a lack of sustainable access to safe and nutritious food. In this article, we discuss the causes and consequences of food insecurity in the developing world, and the indirect economic impact on industrialized countries. We dissect the healthcare costs and lost productivity caused by food insecurity, and evaluate the relative merits of different intervention programs including supplementation, fortification and the deployment of GE crops with higher yields and enhanced nutritional properties. We provide clear evidence for the numerous potential benefits of GE crops, particularly for small-scale and subsistence farmers. GE crops with enhanced yields and nutritional properties constitute a vital component of any comprehensive strategy to tackle poverty, hunger and malnutrition in developing countries and thus reduce the global negative economic effects of food insecurity., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA1006: Plant Engine: Plant metabolic engineering for high value products; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Engineering metabolic pathways in plants by multigene transformation

  • Zorrilla López, Uxue
  • Masip Vilà, Gemma
  • Arjó Pont, Gemma
  • Bai, Chao
  • Banakar, Raviraj
  • Bassie Rene, Ludovic
  • Berman Quintana, Judit
  • Farré Martinez, Gemma
  • Miralpeix i Anglada, Bruna
  • Pérez Massot, Eduard
  • Sabalza Gallués, Maite
  • Sanahuja Solsona, Georgina
  • Vamvaka, Evangelia
  • Twyman, Richard M.
  • Christou, Paul
  • Zhu, Changfu
  • Capell Capell, Teresa
Metabolic engineering in plants can be used to increase the abundance of specific valuable metabolites, but single-point interventions generally do not improve the yields of target metabolites unless that product is immediately downstream of the intervention point and there is a plentiful supply of precursors. In many cases, an intervention is necessary at an early bottleneck, sometimes the first committed step in the pathway, but is often only successful in shifting the bottleneck downstream, sometimes also causing the accumulation of an undesirable metabolic intermediate. Occasionally it has been possible to induce multiple genes in a pathway by controlling the expression of a key regulator, such as a transcription factor, but this strategy is only possible if such master regulators exist and can be identified. A more robust approach is the simultaneous expression of multiple genes in the pathway, preferably representing every critical enzymatic step, therefore removing all bottlenecks and ensuring completely unrestricted metabolic flux. This approach requires the transfer of multiple enzyme-encoding genes to the recipient plant, which is achieved most efficiently if all genes are transferred at the same time. Here we review the state of the art in multigene transformation as applied to metabolic engineering in plants, highlighting some of the most significant recent advances in the field., Research at the Universitat de Lleida is supported by the Ministerio de Ciencia e Innovación (grants no. BFU2007-61413, BIO2011-23324, BIO02011-22525, PIM2010PKB-0074, Acciones complementarias BIO2007-30738-E and BIO2011-22525, and the Centre CONSOLIDER on Agrigenomics), the European Union Framework 7 Program (SmartCell Integrated Project 222716), the European Research Council IDEAS Advanced Grant Program (BIOFORCE) (to PC), the European Cooperation in Science and Technology (COST Action FA0804), and RecerCaixa.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Bacillus thuringiensis: a century of research, development and commercial applications

  • Sanahuja Solsona, Georgina
  • Banakar, Raviraj
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
Bacillus thuringiensis (Bt) is a soil bacterium that forms spores during the stationary phase of its growth cycle. The spores contain crystals, predominantly comprising one or more Cry and/or Cyt proteins (also known as δ-endotoxins) that have potent and specific insecticidal activity. Different strains of Bt produce different types of toxin, each of which affects a narrow taxonomic group of insects. Therefore, Bt toxins have been used as topical pesticides to protect crops, and more recently the proteins have been expressed in transgenic plants to confer inherent pest resistance. Bt transgenic crops have been overwhelmingly successful and beneficial, leading to higher yields and reducing the use of chemical pesticides and fossil fuels. However, their deployment has attracted some criticism particularly with regard to the potential evolution of pest-resistant insect strains. Here, we review recent progress in the development of Bt technology and the countermeasures that have been introduced to prevent the evolution of resistant insect populations., Research in our laboratory is supported by Ministry of Science and Innovation-MICINN (Grant BFU2007-61413); European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804; Associated Unit CAVA; and SmartCell, FP7 Integrated Project.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

The potential impact of plant biotechnology on the Millennium Development Goals

  • Yuan, Dawei
  • Bassie Rene, Ludovic
  • Sabalza Gallués, Maite
  • Miralpeix i Anglada, Bruna
  • Dashevskaya, Svetlana
  • Farré Martinez, Gemma
  • Rivera Vélez, Sol Maiam
  • Banakar, Raviraj
  • Bai, Chao
  • Sanahuja Solsona, Georgina
  • Arjó Pont, Gemma
  • Avilla, Eva
  • Zorrilla López, Uxue
  • Ugidos-Damboriena, Nerea
  • López, Alberto
  • Almacellas, David
  • Zhu, Changfu
  • Capell Capell, Teresa
  • Hahne, Gunther
  • Twyman, Richard M.
  • Christou, Paul
The eight Millennium Development Goals (MDGs) are international development targets for the year 2015 that aim to achieve relative improvements in the standards of health, socioeconomic status and education in the world’s poorest countries. Many of the challenges addressed by the MDGs reflect the direct or indirect consequences of subsistence agriculture in the developing world, and hence, plant biotechnology has an important role to play in helping to achieve MDG targets. In this opinion article, we discuss each of the MDGs in turn, provide examples to show how plant biotechnology may be able to accelerate progress towards the stated MDG objectives, and offer our opinion on the likelihood of such technology being implemented. In combination with other strategies, plant biotechnology can make a contribution towards sustainable development in the future although the extent to which progress can be made in today’s political climate depends on how we deal with current barriers to adoption., Research in our laboratory is supported by Ministry of Science and Innovation-MICINN, Spain (Grant BFU2007-61413); European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA and SmartCell, FP7 Integrated project.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Biofortification of plants with altered antioxidant content and composition: genetic engineering strategies

  • Changfu, Zhu
  • Sanahuja Solsona, Georgina
  • Yuan, Dawei
  • Farré Martinez, Gemma
  • Arjó Pont, Gemma
  • Berman Quintana, Judit
  • Zorrilla López, Uxue
  • Banakar, Raviraj
  • Bai, Chao
  • Pérez Massot, Eduard
  • Bassie Rene, Ludovic
  • Capell Capell, Teresa
  • Christou, Paul
Antioxidants are protective molecules that neutralize reactive oxygen species and prevent oxidative damage to cellular components such as membranes, proteins and nucleic acids, therefore reducing the rate of cell death and hence the effects of ageing and ageing-related diseases. The fortification of food with antioxidants represents an overlap between two diverse environments, namely fortification of staple foods with essential nutrients that happen to have antioxidant properties (e.g. vitamins C and E) and the fortification of luxury foods with healthpromoting but non-essential antioxidants such as flavonoids as part of the nutraceuticals/ functional foods industry. Although processed foods can be artificially fortified with vitamins, minerals and nutraceuticals, a more sustainable approach is to introduce the traits for such health-promoting compounds at source, an approach known as biofortification. Regardless of the target compound, the same challenges arise when considering the biofortification of plants with antioxidants, that is the need to modulate endogenous metabolic pathways to increase the production of specific antioxidants without affecting plant growth and development and without collateral effects on other metabolic pathways. These challenges become even more intricate as we move from the engineering of individual pathways to several pathways simultaneously. In this review, we consider the state of the art in antioxidant biofortification and discuss the challenges that remain to be overcome in the development of nutritionally complete and health-promoting functional foods., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); Acciones complementarias, BIO2007- 30738-E, BIO2011-22525, MICINN, Spain; European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

A golden era—pro-vitamin A enhancement in diverse crops

  • Bai, Chao
  • Twyman, Richard M.
  • Farré Martinez, Gemma
  • Sanahuja Solsona, Georgina
  • Christou, Paul
  • Capell Capell, Teresa
  • Zhu, Changfu
Numerous crops have been bred or engineered to increase carotenoid levels in an effort to develop novel strategies that address vitamin A deficiency in the developing world. The pioneering work in rice (not covered in this review) has been followed up in many additional crops, some of which are staples like rice whereas others are luxury products whose impact on food security is likely to be marginal. This review surveys the progress that has been made in carotenoid breeding and metabolic engineering, focusing on β-carotene enhancement in crops other than rice. We ask if these efforts have the potential to address vitamin A deficiency in developing countries by comparing bioavailable pro-vitamin A levels in wild type and enhanced crops to determine whether nutritional requirements can be met without the consumption of unrealistic amounts of food. The potential impact of carotenoid enhancement should therefore be judged against benchmarks that include the importance of particular crops in terms of global food security, the amount of bioavailable β-carotene, and the amount of food that must be consumed to achieve the reference daily intake of vitamin A., Research in our laboratory is supported by the Ministry of Science and Innovation (MICINN) Grant BFU2007- 61413; European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA; and the SmartCell, FP7 Integrated Project.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Paradoxical EU agricultural policies on genetically engineered crops

  • Masip Vilà, Gemma
  • Sabalza Gallués, Maite
  • Pérez Massot, Eduard
  • Banakar, Raviraj
  • Cebrian, David
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Albajes Garcia, Ramon
  • Christou, Paul
European Union (EU) agricultural policy has been developed in the pursuit of laudable goals such as a competitive economy and regulatory harmony across the union. However, what has emerged is a fragmented, contradictory, and unworkable legislative framework that threatens economic disaster. In this review, we present case studies highlighting differences in the regulations applied to foods grown in EU countries and identical imported products, which show that the EU is undermining its own competitiveness in the agricultural sector, damaging both the EU and its humanitarian activities in the developing world. We recommend the adoption of rational, science-based principles for the harmonization of agricultural policies to prevent economic decline and lower standards of living across the continent., Research at the University of Lleida is supported by the Ministerio de Ciencia e Innovación (MICINN), Spain (BFU2007-61413; BIO2011- 23324; BIO02011-22525; PIM2010PKB-00746; AGL2011-23996); the European Union Framework 7 Program SmartCell Integrated Project 222716; the European Union Framework 7 European Research Council IDEAS Advanced Grant (to P.C.); Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Plurality of opinion, scientific discourse and pseudoscience: an in depth analysis of the Séralini et al. study claiming that Roundup™ Ready corn or the herbicide Roundup™ cause cancer in rats

  • Arjó Pont, Gemma
  • Portero Otín, Manuel
  • Piñol Felis, Carme
  • Viñas Salas, Joan
  • Matias-Guiu, Xavier
  • Capell Capell, Teresa
  • Bartholomaeus, Andrew
  • Parrot, Wayne
  • Christou, Paul
A recent paper published in the journal Food and Chemical Toxicology presents the results of a long-term toxicity study related to a widely-used commercial herbicide (RoundupTM) and a Rounduptolerant genetically modified variety of maize, concluding that both the herbicide and the maize varieties are toxic. Here we discuss the many errors and inaccuracies in the published article resulting in highly misleading conclusions, whose publication in the scientific literature and in the wider media has caused damage to the credibility of science and researchers in the field. We and many others have criticized the study, and in particular the manner in which the experiments were planned, implemented, analyzed, interpreted and communicated. The study appeared to sweep aside all known benchmarks of scientific good practice and, more importantly, to ignore the minimal standards of scientific and ethical conduct in particular concerning the humane treatment of experimental animals., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011- 23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804:Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain. Authors declare that their funding is exclusively from public bodies.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Field trials and tribulations—making sense of the regulations for experimental field trials of transgenic crops in Europe

  • Gómez Galera, Sonia
  • Twyman, Richard M.
  • Sparrow, Penelope A.C.
  • Van Droogenbroeck, Bart
  • Custers, René
  • Capell Capell, Teresa
  • Christou, Paul
Transgenic plants that are being developed for commercial cultivation must be tested underfield conditions to monitor their effects on surrounding wildlife and conventional crops. Devel-opers also use this opportunity to evaluate the performance of transgenic crops in a typicalenvironment, although this is a matter of commercial necessity rather than regulatory compli-ance. Most countries have adapted existing regulations or developed new ones to deal specif-ically with transgenic crops and their commodities. The European Union (EU) is renowned, orperhaps notorious, for having the broadest and most stringent regulations governing suchfield trials in the world. This reflects its nominal adherence to the precautionary approach,which assumes all transgenic crops carry an inherent risk. Therefore, field trials in the EU needto demonstrate that the risk associated with deploying a transgenic crop has been reduced tothe level where it is regarded as acceptable within the narrowly defined limits of the regula-tions developed and enforced (albeit inconsistently) by national and regional governments,that is, that there is no greater risk than growing an equivalent conventional crop. Theinvolvement of national and regional competent authorities in the decision-making processcan add multiple layers of bureaucracy to an already-intricate process. In this review, we usecountry-based case studies to show how the EU, national and regional regulations are imple-mented, and we propose strategies that could increase the efficiency of regulation withoutburdening developers with further unnecessary bureaucracy., Research at the Universitat de Lleida is supported by MICINN,Spain (BFU2007-61413); European Union Framework 7 Pro-gram-SmartCell Integrated Project 222716; European UnionFramework 7 European Research Council IDEAS AdvancedGrant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high valueproteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Strategic patent analysis in plant biotechnology: terpenoid indole alkaloid metabolic engineering as a case study

  • Miralpeix i Anglada, Bruna
  • Sabalza Gallués, Maite
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
The do-it-yourself patent search is a useful alternative to professional patent analysis particularly in the context of publicly funded projects where funds for IP activities may be limited. As a case study, we analysed patents related to the engineering of terpenoid indole alkaloid (TIA) metabolism in plants. We developed a focused search strategy to remove redundancy and reduce the workload without missing important and relevant patents. This resulted in the identification of approximately 50 key patents associated with TIA metabolic engineering in plants, which could form the basis of a more detailed freedom-to-operate analysis. The structural elements of this search strategy could easily be transferred to other contexts, making it a useful generic model for publicly funded research projects, We acknowledge financial support from the European Union Framework 7 Program SmartCell (Integrated Project 222716) and COST Action FA1006: PlantEngine: Plant Metabolic Engineering for High Value Products
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Building bridges: an integrated strategy for sustainable food production throughout the value chain

  • Albajes Garcia, Ramon
  • Cantero-Martínez, Carlos
  • Capell Capell, Teresa
  • Christou, Paul
  • Farré Martinez, Alba
  • Galceran i Nogués, Josep
  • López Gatius, Fernando
  • Marín Sillué, Sònia
  • Martín Belloso, Olga
  • Motilva Casado, Mª José
  • Nogareda, Carmina
  • Pemán García, Jesús
  • Puy Llorens, Jaume
  • Recasens i Guinjuan, Jordi
  • Romagosa Clariana, Ignacio
  • Romero Fabregat, Mª Paz
  • Sanchís Almenar, Vicente
  • Savin, Roxana
  • Slafer, Gustavo A.
  • Soliva-Fortuny, Robert
  • Viñas Almenar, Inmaculada
  • Voltas Velasco, Jordi
The food production and processing value chain is under pressure from all sides-increasing demand driven by a growing and more affluent population; dwindling resources caused by urbanization, land erosion, pollution and competing agriculture such as biofuels; and increasing constraints on production methods driven by consumers and regulators demanding higher quality, reduced chemical use, and most of all environmentally beneficial practices 'from farm to fork'. This pressure can only be addressed by developing efficient and sustainable agricultural practices that are harmonized throughout the value chain, so that renewable resources can be exploited without damaging the environment. Bridges must, therefore, be built between the diverse areas within the food production and processing value chain, including bridges between different stages of production, between currently unlinked agronomic practices, and between the different levels and areas of research to achieve joined-up thinking within the industry, so that the wider impact of different technologies, practices and materials on productivity and sustainability is understood at the local, regional, national and global scales. In this article, we consider the challenges at different stages and levels of the value chain and how new technologies and strategies could be used to build bridges and achieve more sustainable food/feed production in the future., Research at the University of Lleida is supported by MINECO, Spain (AGL2009-11006; AGL2009-11475; AGL2009-11964; AGL2009-13517-C03-02; AGL2010-21572; AGL-22050-C03-01; AGL2010-22084-CO2-O1; AGL2010-22182; AGL2011-23996; AGL2011-24862; AGL2011-30529-C02-02; AGL2012-35300; AGL2012-40144-C03-03; BIO2011-22525; BIO2011-23324; BIO2007-61413; CTQ2009-07831; CTM2009-14612 and PIM2010PKB-00746); EU FP7 Integrated Project 222716 SmartCell; EU FP7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; EU FP7 Large-scale integrated project KBBE 222738 Selection and improving of fit-for-purpose sampling procedures for specific foods and risks (BASELINE); EU FP7 Program-SICA project KBBE 222690; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA 1006: Plant Engine; COST Action TD1104: Development of electroporation-based technologies; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain; the HENUFOOD project (CEN-20101016) as part of the CENIT program and the INCOMES project as part of the INNPRONTA 2011.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

A question of balance: achieving appropriate nutrient levels in biofortified staple crops

  • Sanahuja Solsona, Georgina
  • Farré Martinez, Gemma
  • Berman Quintana, Judit
  • Zorrilla López, Uxue
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
  • Zhu, Changfu
The biofortification of staple crops with vitamins is an attractive strategy to increase the nutritional quality of human food, particularly in areas where the population subsists on a cereal-based diet. Unlike other approaches, biofortification is sustainable and does not require anything more than a standard food-distribution infrastructure. The health-promoting effects of vitamins depend on overall intake and bioavailability, the latter influenced by food processing, absorption efficiency and the utilisation or retention of the vitamin in the body. The bioavailability of vitamins in nutritionally enriched foods should ideally be adjusted to achieve the dietary reference intake in a reasonable portion. Current vitamin biofortification programmes focus on the fat-soluble vitamins A and E, and the water-soluble vitamins C and B9 (folate), but the control of dosage and bioavailability has been largely overlooked. In the present review, we discuss the vitamin content of nutritionally enhanced foods developed by conventional breeding and genetic engineering, focusing on dosage and bioavailability. Although the biofortification of staple crops could potentially address micronutrient deficiency on a global scale, further research is required to develop effective strategies that match the bioavailability of vitamins to the requirements of the human diet., Research at the Universitat de Lleida is supported by MICINN (Ministerio de Ciencia e Innovacion), Spain (BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (toP.C.)Program-BIOFORCE;COSTActionFA0804:Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Nutritious crops producing multiple carotenoids – a metabolic balancing act

  • Farré Martinez, Gemma
  • Bai, Chao
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
  • Zhu, Changfu
Plants and microbes produce multiple carotenoid pigments with important nutritional roles in animals. By unraveling the basis of carotenoid biosynthesis it has become possible to modulate the key metabolic steps in plants and thus increase the nutritional value of staple crops, such as rice (Oryza sativa), maize (Zea mays) and potato (Solanum tuberosum). Multigene engineering has been used to modify three different metabolic pathways simultaneously, producing maize seeds with higher levels of carotenoids, folate and ascorbate. This strategy may allow the development of nutritionally enhanced staples providing adequate amounts of several unrelated nutrients. By focusing on different steps in the carotenoid biosynthesis pathway, it is also possible to generate plants with enhanced levels of several nutritionally-beneficial carotenoid molecules simultaneously., Research in our laboratory is supported by the Ministry of Science and Innovation (MICINN) Grant BFU2007-61413; European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA; and the SmartCell, FP7 Integrated Project.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Plant Cells as Pharmaceutical Factories

  • Rischer, Heiko
  • Häkkinen, Suvi T.
  • Ritala, Anneli
  • Seppänen-Laakso, Tuulikki
  • Miralpeix i Anglada, Bruna
  • Capell Capell, Teresa
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
Molecules derived from plants make up a sizeable proportion of the drugs currently available on the market. These include a number of secondary metabolite compounds the monetary value of which is very high. New pharmaceuticals often originate in nature. Approximately 50% of new drug entities against cancer or microbial infections are derived from plants or micro-organisms. However, these compounds are structurally often too complex to be economically manufactured by chemical synthesis, and frequently isolation from naturally grown or cultivated plants is not a sustainable option. Therefore the biotechnological production of high-value plant secondary metabolites in cultivated cells is potentially an attractive alternative. Compared to microbial systems eukaryotic organisms such as plants are far more complex, and our understanding of the metabolic pathways in plants and their regulation at the systems level has been rather poor until recently. However, metabolic engineering including advanced multigene transformation techniques and state-of-art metabolomics platforms has given us entirely new tools to exploit plants as Green Factories. Single step engineering may be successful on occasion but in complex pathways, intermediate gene interventions most often do not affect the end product accumulation. In this review we discuss recent developments towards elucidation of complex plant biosynthetic pathways and the production of a number of highvalue pharmaceuticals including paclitaxel, tropane, morphine and terpenoid indole alkaloids in plants and cell cultures., VTT and UdL gratefully acknowledge support from European Union Framework 7 Program Integrated Project 222716 SmartCell; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Actions FA0804 Molecular farming: plants as a production platform for high value proteins and FA1006 Plant Metabolic Engineering for High Value Products.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Seeds as a production system for molecular pharming applications: status and prospects

  • Sabalza Gallués, Maite
  • Vamvaka, Evangelia
  • Christou, Paul
  • Capell Capell, Teresa
The production of recombinant proteins in seeds is achieved by driving transgene expression using promoters and protein targeting sequences derived from genes encoding abundant seed storage proteins. This approach is advantageous because high yields, stability and containment are conferred by the accumulation of recombinant proteins in specialized storage compartments such as protein bodies and protein storage vacuoles. Seeds are particularly suitable for the production of pharmaceutical proteins in developing country settings because they reduce the costs of production and distribution by avoiding the need for fermenter-based production capacity and a cold chain for storage and distribution, thus increasing access to critical medicines for the poor in rural areas. Seeds are also ideal for the production of oral vaccine antigens, because encapsulation within the seed provides protection that prolongs exposure to the gastric immune system and thus increases the potency of the immune response. In this review we discuss the current state of the art in seed-based molecular pharming and the future potential of production platforms based on seeds., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program- SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies

  • Ma, Julian K-C.
  • Christou, Paul
  • Chikwamba, Rachel
  • Haydon, Hugh
  • Paul, Mathew J.
  • Pujol Ferrer, Merardo
  • Ramalingam, Sathishkumar
  • Rech, Elibio
  • Rybicki, Edward
  • Wigdorowitz, Andres
  • Yang, Dai-Chang
  • Thangaraj, Harry
Molecular Pharming, the production of recombinant pharmaceuticals through plant biotechnology, has the potential to transform the biologics sector of the pharmaceutical industry. More fascinating however, is how it might be used to improve access to modern medicines, and improve health of the poor in developing countries and emerging economies. Although improving global health through molecular pharming has been discussed for at least two decades, little progress has actually been made. In this manuscript, a four point plan is described to maximise the opportunity for molecular pharming to provide solutions. These are (i) to identify and prioritise important drug targets that are relevant to the poor; (ii) to support research and development partners in low to middle income countries to develop local expertise, transfer technology and build capacity; (iii) to increase collaboration between regulatory bodies to enable national regulatory frameworks to be developed in low to middle income countries; and (iv) to promote intellectual property management approaches that include socially responsible licensing. An existing case study is described to illustrate how this might be achieved., This work was supported by the European COST Action on Molecular Farming (FA804), the EU FP7 project—Access to Pharmaceuticals (ATP) and the ERC Future-Pharma Project. Julian Ma’s research group is also grateful to The Hotung Foundation, The Bill and Melinda Gates Foundation and The Wellcome Trust. Research at the Universitat de Lleida is supported by MICINN, Spain (BIO2011-23324; BIO02011-22525; BIO2012-35359; PIM2010PKB-00746); EU FP7 project SmartCell; EU Framework 7 ERC IDEAS Advanced Grant -BIOFORCE; Research at EMBRAPA is supported by the National Council for Scientific and Technological Development, Coordination for the Improvement of Higher Education Personnel (CAPES), Fundacao de Apoio a Pesquisa and Embrapa Genetic Resources and Biotechnology, Brazil. Work at Bharathiar University is supported by UKIERI, DST-FIST, UGC-SAP.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

The Protein quality control system manages plant defence compound synthesis

  • Pollier, Jacob
  • Moses, Tessa
  • González-Guzmán, Miguel
  • De Geyter, Nathan
  • Lippens, Saskia
  • Bossche, Robin Vanden
  • Marhavý, Peter
  • Kremer, Anna
  • Morreel, Kris
  • Guérin, Christopher J.
  • Tava, Aldo
  • Oleszek, Wieslaw
  • Thevelein, Johan M.
  • Campos Martínez, Narciso
  • Goormachtig, Sofie
  • Goossens, Alain
Jasmonates are ubiquitous oxylipin-derived phytohormones that are essential in the regulation of many development, growth and defence processes. Across the plant kingdom, jasmonates act as elicitors of the production of bioactive secondarymetabolites that serve in defence against attackers. Knowledge of the conserved jasmonate perception and early signalling machineries is increasing, but the downstream mechanisms that regulate defence metabolism remain largely unknown. Herewe showthat, in the legumeMedicago truncatula, jasmonate recruits the endoplasmic-reticulum-associated degradation (ERAD)quality control system tomanagethe production of triterpene saponins, widespread bioactive compounds that share a biogenic origin with sterols. An ERAD-type RING membraneanchor E3 ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in the supply of the ubiquitous terpene precursor isopentenyl diphosphate. Thus, unrestrained bioactive saponin accumulationis prevented and plant development and integrity secured. This control apparatus is equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals but that uses distinct E3 ubiquitin ligases, of the HMGR degradation 1 (HRD1) type, to direct destruction of HMGR. Hence, the general principles for the management of sterol and triterpene saponin biosynthesis are conserved across eukaryotes but can be controlled by divergent regulatory cues.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The protein quality control system manages plant defence compound synthesis

  • Pollier, Jacob
  • Moses, Tessa
  • González-Guzmán, Miguel
  • De Geyter, Nathan
  • Lippens, Saskia
  • Vanden Bossche, Robin
  • Marhavý, Peter
  • Kremer, Anna
  • Morreel, Kris
  • Guérin, Christopher J.
  • Tava, Aldo
  • Oleszek, Wieslaw
  • Thevelein, Johan M.
  • Campos, Narciso
  • Goormachtig, Sofie
  • Goossens, Alain
Jasmonates are ubiquitous oxylipin-derived phytohormones that are essential in the regulation of many development, growth and defence processes. Across the plant kingdom, jasmonates act as elicitors of the production of bioactive secondary metabolites that serve in defence against attackers. Knowledge of the conserved jasmonate perception and early signalling machineries is increasing, but the downstream mechanisms that regulate defence metabolism remain largely unknown. Here we show that, in the legume Medicago truncatula, jasmonate recruits the endoplasmic-reticulum-associated degradation (ERAD) quality control system to manage the production of triterpene saponins, widespread bioactive compounds that share a biogenic origin with sterols. An ERAD-type RING membrane-anchor E3 ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in the supply of the ubiquitous terpene precursor isopentenyl diphosphate. Thus, unrestrained bioactive saponin accumulation is prevented and plant development and integrity secured. This control apparatus is equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals but that uses distinct E3 ubiquitin ligases, of the HMGR degradation 1 (HRD1) type, to direct destruction of HMGR. Hence, the general principles for the management of sterol and triterpene saponin biosynthesis are conserved across eukaryotes but can be controlled by divergent regulatory cues., This research has received funding from the Agency for Innovation by Science and Technology in Flanders (‘Strategisch Basisonderzoek’ Combiplan project SBO040093), the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 222716 –SMARTCELL and the Spanish Ministerio de Economía y Competitividad under grant BFU2011-24208. T.M. and N.D.G. are indebted to the VIB International PhD Fellowship Program and the Agency for Innovation by Science and Technology for predoctoral fellowships, respectively. J.P. and S.L. are postdoctoral fellows of the Research Foundation Flanders (FWO)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Plant Cells as Pharmaceutical Factories

  • Rischer, Heiko
  • Häkkinen, Suvi T.
  • Ritala, Anneli
  • Seppänen-Laakso, Tuulikki
  • Miralpeix i Anglada, Bruna
  • Capell Capell, Teresa
  • Christou, Paul
  • Oksman-Caldentey, Kirsi-Marja
Molecules derived from plants make up a sizeable proportion of the drugs currently available on the market. These include a number of secondary metabolite compounds the monetary value of which is very high. New pharmaceuticals often originate in nature. Approximately 50% of new drug entities against cancer or microbial infections are derived from plants or micro-organisms. However, these compounds are structurally often too complex to be economically manufactured by chemical synthesis, and frequently isolation from naturally grown or cultivated plants is not a sustainable option. Therefore the biotechnological production of high-value plant secondary metabolites in cultivated cells is potentially an attractive alternative. Compared to microbial systems eukaryotic organisms such as plants are far more complex, and our understanding of the metabolic pathways in plants and their regulation at the systems level has been rather poor until recently. However, metabolic engineering including advanced multigene transformation techniques and state-of-art metabolomics platforms has given us entirely new tools to exploit plants as Green Factories. Single step engineering may be successful on occasion but in complex pathways, intermediate gene interventions most often do not affect the end product accumulation. In this review we discuss recent developments towards elucidation of complex plant biosynthetic pathways and the production of a number of highvalue pharmaceuticals including paclitaxel, tropane, morphine and terpenoid indole alkaloids in plants and cell cultures., VTT and UdL gratefully acknowledge support from European Union Framework 7 Program Integrated Project 222716 SmartCell; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Actions FA0804 Molecular farming: plants as a production platform for high value proteins and FA1006 Plant Metabolic Engineering for High Value Products.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Plurality of opinion, scientific discourse and pseudoscience: an in depth analysis of the Séralini et al. study claiming that Roundup™ Ready corn or the herbicide Roundup™ cause cancer in rats

  • Arjó Pont, Gemma
  • Portero Otín, Manuel
  • Piñol Felis, Carme
  • Viñas Salas, Joan
  • Matias-Guiu, Xavier
  • Capell Capell, Teresa
  • Bartholomaeus, Andrew
  • Parrot, Wayne
  • Christou, Paul
A recent paper published in the journal Food and Chemical Toxicology presents the results of a long-term toxicity study related to a widely-used commercial herbicide (RoundupTM) and a Rounduptolerant genetically modified variety of maize, concluding that both the herbicide and the maize varieties are toxic. Here we discuss the many errors and inaccuracies in the published article resulting in highly misleading conclusions, whose publication in the scientific literature and in the wider media has caused damage to the credibility of science and researchers in the field. We and many others have criticized the study, and in particular the manner in which the experiments were planned, implemented, analyzed, interpreted and communicated. The study appeared to sweep aside all known benchmarks of scientific good practice and, more importantly, to ignore the minimal standards of scientific and ethical conduct in particular concerning the humane treatment of experimental animals., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011- 23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804:Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain. Authors declare that their funding is exclusively from public bodies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The potential impact of plant biotechnology on the Millennium Development Goals

  • Yuan, Dawei
  • Bassie Rene, Ludovic
  • Sabalza Gallués, Maite
  • Miralpeix i Anglada, Bruna
  • Dashevskaya, Svetlana
  • Farré Martinez, Gemma
  • Rivera Vélez, Sol Maiam
  • Banakar, Raviraj
  • Bai, Chao
  • Sanahuja Solsona, Georgina
  • Arjó Pont, Gemma
  • Avilla, Eva
  • Zorrilla López, Uxue
  • Ugidos-Damboriena, Nerea
  • López, Alberto
  • Almacellas, David
  • Zhu, Changfu
  • Capell Capell, Teresa
  • Hahne, Gunther
  • Twyman, Richard M.
  • Christou, Paul
The eight Millennium Development Goals (MDGs) are international development targets for the year 2015 that aim to achieve relative improvements in the standards of health, socioeconomic status and education in the world’s poorest countries. Many of the challenges addressed by the MDGs reflect the direct or indirect consequences of subsistence agriculture in the developing world, and hence, plant biotechnology has an important role to play in helping to achieve MDG targets. In this opinion article, we discuss each of the MDGs in turn, provide examples to show how plant biotechnology may be able to accelerate progress towards the stated MDG objectives, and offer our opinion on the likelihood of such technology being implemented. In combination with other strategies, plant biotechnology can make a contribution towards sustainable development in the future although the extent to which progress can be made in today’s political climate depends on how we deal with current barriers to adoption., Research in our laboratory is supported by Ministry of Science and Innovation-MICINN, Spain (Grant BFU2007-61413); European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA and SmartCell, FP7 Integrated project.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Nutritious crops producing multiple carotenoids – a metabolic balancing act

  • Farré Martinez, Gemma
  • Bai, Chao
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
  • Zhu, Changfu
Plants and microbes produce multiple carotenoid pigments with important nutritional roles in animals. By unraveling the basis of carotenoid biosynthesis it has become possible to modulate the key metabolic steps in plants and thus increase the nutritional value of staple crops, such as rice (Oryza sativa), maize (Zea mays) and potato (Solanum tuberosum). Multigene engineering has been used to modify three different metabolic pathways simultaneously, producing maize seeds with higher levels of carotenoids, folate and ascorbate. This strategy may allow the development of nutritionally enhanced staples providing adequate amounts of several unrelated nutrients. By focusing on different steps in the carotenoid biosynthesis pathway, it is also possible to generate plants with enhanced levels of several nutritionally-beneficial carotenoid molecules simultaneously., Research in our laboratory is supported by the Ministry of Science and Innovation (MICINN) Grant BFU2007-61413; European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA; and the SmartCell, FP7 Integrated Project.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Seeds as a production system for molecular pharming applications: status and prospects

  • Sabalza Gallués, Maite
  • Vamvaka, Evangelia
  • Christou, Paul
  • Capell Capell, Teresa
The production of recombinant proteins in seeds is achieved by driving transgene expression using promoters and protein targeting sequences derived from genes encoding abundant seed storage proteins. This approach is advantageous because high yields, stability and containment are conferred by the accumulation of recombinant proteins in specialized storage compartments such as protein bodies and protein storage vacuoles. Seeds are particularly suitable for the production of pharmaceutical proteins in developing country settings because they reduce the costs of production and distribution by avoiding the need for fermenter-based production capacity and a cold chain for storage and distribution, thus increasing access to critical medicines for the poor in rural areas. Seeds are also ideal for the production of oral vaccine antigens, because encapsulation within the seed provides protection that prolongs exposure to the gastric immune system and thus increases the potency of the immune response. In this review we discuss the current state of the art in seed-based molecular pharming and the future potential of production platforms based on seeds., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program- SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Strategic patent analysis in plant biotechnology: terpenoid indole alkaloid metabolic engineering as a case study

  • Miralpeix i Anglada, Bruna
  • Sabalza Gallués, Maite
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
The do-it-yourself patent search is a useful alternative to professional patent analysis particularly in the context of publicly funded projects where funds for IP activities may be limited. As a case study, we analysed patents related to the engineering of terpenoid indole alkaloid (TIA) metabolism in plants. We developed a focused search strategy to remove redundancy and reduce the workload without missing important and relevant patents. This resulted in the identification of approximately 50 key patents associated with TIA metabolic engineering in plants, which could form the basis of a more detailed freedom-to-operate analysis. The structural elements of this search strategy could easily be transferred to other contexts, making it a useful generic model for publicly funded research projects, We acknowledge financial support from the European Union Framework 7 Program SmartCell (Integrated Project 222716) and COST Action FA1006: PlantEngine: Plant Metabolic Engineering for High Value Products
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A golden era—pro-vitamin A enhancement in diverse crops

  • Bai, Chao
  • Twyman, Richard M.
  • Farré Martinez, Gemma
  • Sanahuja Solsona, Georgina
  • Christou, Paul
  • Capell Capell, Teresa
  • Zhu, Changfu
Numerous crops have been bred or engineered to increase carotenoid levels in an effort to develop novel strategies that address vitamin A deficiency in the developing world. The pioneering work in rice (not covered in this review) has been followed up in many additional crops, some of which are staples like rice whereas others are luxury products whose impact on food security is likely to be marginal. This review surveys the progress that has been made in carotenoid breeding and metabolic engineering, focusing on β-carotene enhancement in crops other than rice. We ask if these efforts have the potential to address vitamin A deficiency in developing countries by comparing bioavailable pro-vitamin A levels in wild type and enhanced crops to determine whether nutritional requirements can be met without the consumption of unrealistic amounts of food. The potential impact of carotenoid enhancement should therefore be judged against benchmarks that include the importance of particular crops in terms of global food security, the amount of bioavailable β-carotene, and the amount of food that must be consumed to achieve the reference daily intake of vitamin A., Research in our laboratory is supported by the Ministry of Science and Innovation (MICINN) Grant BFU2007- 61413; European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804, Associated Unit CAVA; and the SmartCell, FP7 Integrated Project.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Engineering metabolic pathways in plants by multigene transformation

  • Zorrilla López, Uxue
  • Masip Vilà, Gemma
  • Arjó Pont, Gemma
  • Bai, Chao
  • Banakar, Raviraj
  • Bassie Rene, Ludovic
  • Berman Quintana, Judit
  • Farré Martinez, Gemma
  • Miralpeix i Anglada, Bruna
  • Pérez Massot, Eduard
  • Sabalza Gallués, Maite
  • Sanahuja Solsona, Georgina
  • Vamvaka, Evangelia
  • Twyman, Richard M.
  • Christou, Paul
  • Zhu, Changfu
  • Capell Capell, Teresa
Metabolic engineering in plants can be used to increase the abundance of specific valuable metabolites, but single-point interventions generally do not improve the yields of target metabolites unless that product is immediately downstream of the intervention point and there is a plentiful supply of precursors. In many cases, an intervention is necessary at an early bottleneck, sometimes the first committed step in the pathway, but is often only successful in shifting the bottleneck downstream, sometimes also causing the accumulation of an undesirable metabolic intermediate. Occasionally it has been possible to induce multiple genes in a pathway by controlling the expression of a key regulator, such as a transcription factor, but this strategy is only possible if such master regulators exist and can be identified. A more robust approach is the simultaneous expression of multiple genes in the pathway, preferably representing every critical enzymatic step, therefore removing all bottlenecks and ensuring completely unrestricted metabolic flux. This approach requires the transfer of multiple enzyme-encoding genes to the recipient plant, which is achieved most efficiently if all genes are transferred at the same time. Here we review the state of the art in multigene transformation as applied to metabolic engineering in plants, highlighting some of the most significant recent advances in the field., Research at the Universitat de Lleida is supported by the Ministerio de Ciencia e Innovación (grants no. BFU2007-61413, BIO2011-23324, BIO02011-22525, PIM2010PKB-0074, Acciones complementarias BIO2007-30738-E and BIO2011-22525, and the Centre CONSOLIDER on Agrigenomics), the European Union Framework 7 Program (SmartCell Integrated Project 222716), the European Research Council IDEAS Advanced Grant Program (BIOFORCE) (to PC), the European Cooperation in Science and Technology (COST Action FA0804), and RecerCaixa.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A question of balance: achieving appropriate nutrient levels in biofortified staple crops

  • Sanahuja Solsona, Georgina
  • Farré Martinez, Gemma
  • Berman Quintana, Judit
  • Zorrilla López, Uxue
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
  • Zhu, Changfu
The biofortification of staple crops with vitamins is an attractive strategy to increase the nutritional quality of human food, particularly in areas where the population subsists on a cereal-based diet. Unlike other approaches, biofortification is sustainable and does not require anything more than a standard food-distribution infrastructure. The health-promoting effects of vitamins depend on overall intake and bioavailability, the latter influenced by food processing, absorption efficiency and the utilisation or retention of the vitamin in the body. The bioavailability of vitamins in nutritionally enriched foods should ideally be adjusted to achieve the dietary reference intake in a reasonable portion. Current vitamin biofortification programmes focus on the fat-soluble vitamins A and E, and the water-soluble vitamins C and B9 (folate), but the control of dosage and bioavailability has been largely overlooked. In the present review, we discuss the vitamin content of nutritionally enhanced foods developed by conventional breeding and genetic engineering, focusing on dosage and bioavailability. Although the biofortification of staple crops could potentially address micronutrient deficiency on a global scale, further research is required to develop effective strategies that match the bioavailability of vitamins to the requirements of the human diet., Research at the Universitat de Lleida is supported by MICINN (Ministerio de Ciencia e Innovacion), Spain (BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (toP.C.)Program-BIOFORCE;COSTActionFA0804:Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metabolic engineering of plant secondary products: which way forward?

  • Miralpeix i Anglada, Bruna
  • Rischer, Heiko
  • Häkkinen, Suvi T.
  • Ritala, Anneli
  • Seppänen-Laakso, Tuulikki
  • Oksman-Caldentey, Kirsi-Marja
  • Capell Capell, Teresa
  • Christou, Paul
Secondary products are small molecular weight compounds produced by secondary metabolic pathways in plants. They are re- garded as non-essential for normal growth and development but often confer benefits such as defense against pathogens, pests an d herbi- vores or the attraction of pollinators. Many secondary products affect the survival and/or behavior of microbes, insects and ma mmals and they often have useful pharmacological effects in humans. Most secondary products can only be obtained as extracts from medicin al plants, many of which grow slowly and are difficult to cultivate. Chemical synthesis, although possible in principle, is often impractical or uneconomical due to the complexity of their molecular structures. The large scale production of secondary products by metabo lic en- gineering has therefore been investigated in a number of heterologous systems including microbes, plant cell/organ cultures, an d intact plants. In this critical review of production platforms for plant secondary products, we discuss the advantages and constraints of different approaches and the impact of post-genomics technologies on gene discovery and metabolite analysis. We highlight bottlenecks that re- main to be overcome before the routine exploitation of secondary products can be achieved for the benefit of mankind., Research is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); Euro- pean Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Ac- tion FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA1006: Plant metabolic engineering for high value products; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies

  • Ma, Julian K-C.
  • Christou, Paul
  • Chikwamba, Rachel
  • Haydon, Hugh
  • Paul, Mathew J.
  • Pujol Ferrer, Merardo
  • Ramalingam, Sathishkumar
  • Rech, Elibio
  • Rybicki, Edward
  • Wigdorowitz, Andres
  • Yang, Dai-Chang
  • Thangaraj, Harry
Molecular Pharming, the production of recombinant pharmaceuticals through plant biotechnology, has the potential to transform the biologics sector of the pharmaceutical industry. More fascinating however, is how it might be used to improve access to modern medicines, and improve health of the poor in developing countries and emerging economies. Although improving global health through molecular pharming has been discussed for at least two decades, little progress has actually been made. In this manuscript, a four point plan is described to maximise the opportunity for molecular pharming to provide solutions. These are (i) to identify and prioritise important drug targets that are relevant to the poor; (ii) to support research and development partners in low to middle income countries to develop local expertise, transfer technology and build capacity; (iii) to increase collaboration between regulatory bodies to enable national regulatory frameworks to be developed in low to middle income countries; and (iv) to promote intellectual property management approaches that include socially responsible licensing. An existing case study is described to illustrate how this might be achieved., This work was supported by the European COST Action on Molecular Farming (FA804), the EU FP7 project—Access to Pharmaceuticals (ATP) and the ERC Future-Pharma Project. Julian Ma’s research group is also grateful to The Hotung Foundation, The Bill and Melinda Gates Foundation and The Wellcome Trust. Research at the Universitat de Lleida is supported by MICINN, Spain (BIO2011-23324; BIO02011-22525; BIO2012-35359; PIM2010PKB-00746); EU FP7 project SmartCell; EU Framework 7 ERC IDEAS Advanced Grant -BIOFORCE; Research at EMBRAPA is supported by the National Council for Scientific and Technological Development, Coordination for the Improvement of Higher Education Personnel (CAPES), Fundacao de Apoio a Pesquisa and Embrapa Genetic Resources and Biotechnology, Brazil. Work at Bharathiar University is supported by UKIERI, DST-FIST, UGC-SAP.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Engineering complex metabolic pathways in plants

  • Farré Martinez, Gemma
  • Capell Capell, Teresa
  • Zhu, Changfu
  • Christou, Paul
  • Blancquaert, Dieter
  • Van Der Straeten, Dominique
Metabolic engineering can be used to modulate endogenous metabolic pathways in plants or introduce new metabolic capabilities in order to increase the production of a desirable compound or reduce the accumulation of an undesirable one. In practice, there are several major challenges that need to be overcome, such as gaining enough knowledge about the endogenous pathways to understand the best intervention points, identifying and sourcing the most suitable metabolic genes, expressing those genes in such a way as to produce a functional enzyme in a heterologous background, and, finally, achieving the accumulation of target compounds without harming the host plant. This article discusses the strategies that have been developed to engineer complex metabolic pathways in plants, focusing on recent technological developments that allow the most significant bottlenecks to be overcome., Research at the Universitat de Lleida is supported by MICINN, Spain (BIO2011-23324, BIO02011-22525, BIO2012-35359, and PIM2010PKB-00746); European Union Framework 7 Program–SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE (to P.C.); RecerCaixa; COST Action FA0804 (Molecular Farming: Plants as a Production Platform for High Value Proteins); and Centre CONSOLIDER on Agrigenomics, funded by MICINN, Spain. Research at Ghent University is supported by Bijzonder Onderzoeksfonds (BOF2004/GOA/012 and BOF2009/GOA/004 to D.V.D.S.) and the Research Foundation Flanders (3G012609 to D.V.D.S.). D.B. is indebted to the Research Foundation Flanders for a PhD fellowship.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Protein quality control system manages plant defence compound synthesis

  • Pollier, Jacob
  • Moses, Tessa
  • González-Guzmán, Miguel
  • De Geyter, Nathan
  • Lippens, Saskia
  • Bossche, Robin Vanden
  • Marhavý, Peter
  • Kremer, Anna
  • Morreel, Kris
  • Guérin, Christopher J.
  • Tava, Aldo
  • Oleszek, Wieslaw
  • Thevelein, Johan M.
  • Campos Martínez, Narciso
  • Goormachtig, Sofie
  • Goossens, Alain
Jasmonates are ubiquitous oxylipin-derived phytohormones that are essential in the regulation of many development, growth and defence processes. Across the plant kingdom, jasmonates act as elicitors of the production of bioactive secondarymetabolites that serve in defence against attackers. Knowledge of the conserved jasmonate perception and early signalling machineries is increasing, but the downstream mechanisms that regulate defence metabolism remain largely unknown. Herewe showthat, in the legumeMedicago truncatula, jasmonate recruits the endoplasmic-reticulum-associated degradation (ERAD)quality control system tomanagethe production of triterpene saponins, widespread bioactive compounds that share a biogenic origin with sterols. An ERAD-type RING membraneanchor E3 ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in the supply of the ubiquitous terpene precursor isopentenyl diphosphate. Thus, unrestrained bioactive saponin accumulationis prevented and plant development and integrity secured. This control apparatus is equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals but that uses distinct E3 ubiquitin ligases, of the HMGR degradation 1 (HRD1) type, to direct destruction of HMGR. Hence, the general principles for the management of sterol and triterpene saponin biosynthesis are conserved across eukaryotes but can be controlled by divergent regulatory cues.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Building bridges: an integrated strategy for sustainable food production throughout the value chain

  • Albajes Garcia, Ramon
  • Cantero-Martínez, Carlos
  • Capell Capell, Teresa
  • Christou, Paul
  • Farré Martinez, Alba
  • Galceran i Nogués, Josep
  • López Gatius, Fernando
  • Marín Sillué, Sònia
  • Martín Belloso, Olga
  • Motilva Casado, Mª José
  • Nogareda, Carmina
  • Pemán García, Jesús
  • Puy Llorens, Jaume
  • Recasens i Guinjuan, Jordi
  • Romagosa Clariana, Ignacio
  • Romero Fabregat, Mª Paz
  • Sanchís Almenar, Vicente
  • Savin, Roxana
  • Slafer, Gustavo A.
  • Soliva-Fortuny, Robert
  • Viñas Almenar, Inmaculada
  • Voltas Velasco, Jordi
The food production and processing value chain is under pressure from all sides-increasing demand driven by a growing and more affluent population; dwindling resources caused by urbanization, land erosion, pollution and competing agriculture such as biofuels; and increasing constraints on production methods driven by consumers and regulators demanding higher quality, reduced chemical use, and most of all environmentally beneficial practices 'from farm to fork'. This pressure can only be addressed by developing efficient and sustainable agricultural practices that are harmonized throughout the value chain, so that renewable resources can be exploited without damaging the environment. Bridges must, therefore, be built between the diverse areas within the food production and processing value chain, including bridges between different stages of production, between currently unlinked agronomic practices, and between the different levels and areas of research to achieve joined-up thinking within the industry, so that the wider impact of different technologies, practices and materials on productivity and sustainability is understood at the local, regional, national and global scales. In this article, we consider the challenges at different stages and levels of the value chain and how new technologies and strategies could be used to build bridges and achieve more sustainable food/feed production in the future., Research at the University of Lleida is supported by MINECO, Spain (AGL2009-11006; AGL2009-11475; AGL2009-11964; AGL2009-13517-C03-02; AGL2010-21572; AGL-22050-C03-01; AGL2010-22084-CO2-O1; AGL2010-22182; AGL2011-23996; AGL2011-24862; AGL2011-30529-C02-02; AGL2012-35300; AGL2012-40144-C03-03; BIO2011-22525; BIO2011-23324; BIO2007-61413; CTQ2009-07831; CTM2009-14612 and PIM2010PKB-00746); EU FP7 Integrated Project 222716 SmartCell; EU FP7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; EU FP7 Large-scale integrated project KBBE 222738 Selection and improving of fit-for-purpose sampling procedures for specific foods and risks (BASELINE); EU FP7 Program-SICA project KBBE 222690; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA 1006: Plant Engine; COST Action TD1104: Development of electroporation-based technologies; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain; the HENUFOOD project (CEN-20101016) as part of the CENIT program and the INCOMES project as part of the INNPRONTA 2011.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Paradoxical EU agricultural policies on genetically engineered crops

  • Masip Vilà, Gemma
  • Sabalza Gallués, Maite
  • Pérez Massot, Eduard
  • Banakar, Raviraj
  • Cebrian, David
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Albajes Garcia, Ramon
  • Christou, Paul
European Union (EU) agricultural policy has been developed in the pursuit of laudable goals such as a competitive economy and regulatory harmony across the union. However, what has emerged is a fragmented, contradictory, and unworkable legislative framework that threatens economic disaster. In this review, we present case studies highlighting differences in the regulations applied to foods grown in EU countries and identical imported products, which show that the EU is undermining its own competitiveness in the agricultural sector, damaging both the EU and its humanitarian activities in the developing world. We recommend the adoption of rational, science-based principles for the harmonization of agricultural policies to prevent economic decline and lower standards of living across the continent., Research at the University of Lleida is supported by the Ministerio de Ciencia e Innovación (MICINN), Spain (BFU2007-61413; BIO2011- 23324; BIO02011-22525; PIM2010PKB-00746; AGL2011-23996); the European Union Framework 7 Program SmartCell Integrated Project 222716; the European Union Framework 7 European Research Council IDEAS Advanced Grant (to P.C.); Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The application of GMOs in agriculture and in food production for a better nutrition: two different scientific points of view

  • Christou, Paul
  • Buiatti, M.
  • Pastore, G.
This commentary is a face-to-face debate between two almost opposite positions regarding the application of genetic engineering in agriculture and food production. Seven questions on the potential benefits of the application of genetic engineering in agriculture and on the potentially adverse impacts on the environment and human health were posed to two scientists: one who is sceptical about the use of GMOs in Agriculture, and one who views GMOs as an important tool for quantitatively and qualitatively improving food production., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Can the world afford to ignore biotechnology solutions that address food insecurity?

  • Berman Quintana, Judit
  • Zhu, Changfu
  • Pérez Massot, Eduard
  • Arjó Pont, Gemma
  • Zorrilla López, Uxue
  • Masip Vilà, Gemma
  • Banakar, Raviraj
  • Sanahuja Solsona, Georgina
  • Farré Martinez, Gemma
  • Miralpeix i Anglada, Bruna
  • Bai, Chao
  • Vamvaka, Evangelia
  • Sabalza Gallués, Maite
  • Twyman, Richard M.
  • Bassie Rene, Ludovic
  • Capell Capell, Teresa
  • Christou, Paul
Genetically engineered (GE) crops can be used as part of a combined strategy to address food insecurity, which is defined as a lack of sustainable access to safe and nutritious food. In this article, we discuss the causes and consequences of food insecurity in the developing world, and the indirect economic impact on industrialized countries. We dissect the healthcare costs and lost productivity caused by food insecurity, and evaluate the relative merits of different intervention programs including supplementation, fortification and the deployment of GE crops with higher yields and enhanced nutritional properties. We provide clear evidence for the numerous potential benefits of GE crops, particularly for small-scale and subsistence farmers. GE crops with enhanced yields and nutritional properties constitute a vital component of any comprehensive strategy to tackle poverty, hunger and malnutrition in developing countries and thus reduce the global negative economic effects of food insecurity., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; COST Action FA1006: Plant Engine: Plant metabolic engineering for high value products; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain and RecerCaixa.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Bacillus thuringiensis: a century of research, development and commercial applications

  • Sanahuja Solsona, Georgina
  • Banakar, Raviraj
  • Twyman, Richard M.
  • Capell Capell, Teresa
  • Christou, Paul
Bacillus thuringiensis (Bt) is a soil bacterium that forms spores during the stationary phase of its growth cycle. The spores contain crystals, predominantly comprising one or more Cry and/or Cyt proteins (also known as δ-endotoxins) that have potent and specific insecticidal activity. Different strains of Bt produce different types of toxin, each of which affects a narrow taxonomic group of insects. Therefore, Bt toxins have been used as topical pesticides to protect crops, and more recently the proteins have been expressed in transgenic plants to confer inherent pest resistance. Bt transgenic crops have been overwhelmingly successful and beneficial, leading to higher yields and reducing the use of chemical pesticides and fossil fuels. However, their deployment has attracted some criticism particularly with regard to the potential evolution of pest-resistant insect strains. Here, we review recent progress in the development of Bt technology and the countermeasures that have been introduced to prevent the evolution of resistant insect populations., Research in our laboratory is supported by Ministry of Science and Innovation-MICINN (Grant BFU2007-61413); European Research Council Advanced Grant BIOFORCE; Center Consolider, MICINN, Spain; COST Action FA0804; Associated Unit CAVA; and SmartCell, FP7 Integrated Project.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Field trials and tribulations—making sense of the regulations for experimental field trials of transgenic crops in Europe

  • Gómez Galera, Sonia
  • Twyman, Richard M.
  • Sparrow, Penelope A.C.
  • Van Droogenbroeck, Bart
  • Custers, René
  • Capell Capell, Teresa
  • Christou, Paul
Transgenic plants that are being developed for commercial cultivation must be tested underfield conditions to monitor their effects on surrounding wildlife and conventional crops. Devel-opers also use this opportunity to evaluate the performance of transgenic crops in a typicalenvironment, although this is a matter of commercial necessity rather than regulatory compli-ance. Most countries have adapted existing regulations or developed new ones to deal specif-ically with transgenic crops and their commodities. The European Union (EU) is renowned, orperhaps notorious, for having the broadest and most stringent regulations governing suchfield trials in the world. This reflects its nominal adherence to the precautionary approach,which assumes all transgenic crops carry an inherent risk. Therefore, field trials in the EU needto demonstrate that the risk associated with deploying a transgenic crop has been reduced tothe level where it is regarded as acceptable within the narrowly defined limits of the regula-tions developed and enforced (albeit inconsistently) by national and regional governments,that is, that there is no greater risk than growing an equivalent conventional crop. Theinvolvement of national and regional competent authorities in the decision-making processcan add multiple layers of bureaucracy to an already-intricate process. In this review, we usecountry-based case studies to show how the EU, national and regional regulations are imple-mented, and we propose strategies that could increase the efficiency of regulation withoutburdening developers with further unnecessary bureaucracy., Research at the Universitat de Lleida is supported by MICINN,Spain (BFU2007-61413); European Union Framework 7 Pro-gram-SmartCell Integrated Project 222716; European UnionFramework 7 European Research Council IDEAS AdvancedGrant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high valueproteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Biofortification of plants with altered antioxidant content and composition: genetic engineering strategies

  • Changfu, Zhu
  • Sanahuja Solsona, Georgina
  • Yuan, Dawei
  • Farré Martinez, Gemma
  • Arjó Pont, Gemma
  • Berman Quintana, Judit
  • Zorrilla López, Uxue
  • Banakar, Raviraj
  • Bai, Chao
  • Pérez Massot, Eduard
  • Bassie Rene, Ludovic
  • Capell Capell, Teresa
  • Christou, Paul
Antioxidants are protective molecules that neutralize reactive oxygen species and prevent oxidative damage to cellular components such as membranes, proteins and nucleic acids, therefore reducing the rate of cell death and hence the effects of ageing and ageing-related diseases. The fortification of food with antioxidants represents an overlap between two diverse environments, namely fortification of staple foods with essential nutrients that happen to have antioxidant properties (e.g. vitamins C and E) and the fortification of luxury foods with healthpromoting but non-essential antioxidants such as flavonoids as part of the nutraceuticals/ functional foods industry. Although processed foods can be artificially fortified with vitamins, minerals and nutraceuticals, a more sustainable approach is to introduce the traits for such health-promoting compounds at source, an approach known as biofortification. Regardless of the target compound, the same challenges arise when considering the biofortification of plants with antioxidants, that is the need to modulate endogenous metabolic pathways to increase the production of specific antioxidants without affecting plant growth and development and without collateral effects on other metabolic pathways. These challenges become even more intricate as we move from the engineering of individual pathways to several pathways simultaneously. In this review, we consider the state of the art in antioxidant biofortification and discuss the challenges that remain to be overcome in the development of nutritionally complete and health-promoting functional foods., Research at the Universitat de Lleida is supported by MICINN, Spain (BFU2007-61413; BIO2011-23324; BIO02011-22525; PIM2010PKB-00746); Acciones complementarias, BIO2007- 30738-E, BIO2011-22525, MICINN, Spain; European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; Centre CONSOLIDER on Agrigenomics funded by MICINN, Spain.